Lisbet Brandi

Lisbet Brandi

Clinical Associate Professor

Member of:

  • Internal Medicine: Nephrology


  1. Published

    Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial

    Bressendorff, I., Hansen, D., Schou, Morten, Silver, B., Pasch, A., Bouchelouche, P., Pedersen, L., Rasmussen, L. M. & Brandi, Lisbet, 2017, In: Kidney International Reports. 2, 3, p. 380-389

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: A randomized, controlled clinical trial

    Bressendorff, I., Hansen, Ditte, Schou, Morten, Pasch, A. & Brandi, Lisbet, 2018, In: Clinical Journal of the American Society of Nephrology. 13, 9, p. 1373-1380 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial

    Bressendorff, I., Hansen, Ditte, Pasch, A., Holt, S. G., Schou, Morten, Brandi, Lisbet & Smith, E. R., 2021, In: Nephrology, Dialysis, Transplantation. 36, 4, p. 713–721 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale

    Bressendorff, I., Hansen, D., Schou, Morten, Kragelund, C. & Brandi, Lisbet, Jun 2017, In: B M J Open. 7, 6, 7 p., e016795.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    One-alpha-hydroxy-cholecalciferol - an active vitamin D analog

    Brandi, Lisbet, 2008, København: Maanedsskrift for Praktisk Laegegerning. 103 p.

    Research output: Book/ReportPh.D. thesisResearch

  6. Published

    Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis

    Brandi, Lisbet, Daugaard, H., Nielsen, P. K., Jensen, Lars Thorbjørn, Egsmose, C. & Ølgaard, Klaus, 1996, In: Nephron Clinical Practice. 74, 1, p. 89-103 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Alfacalcidol in CKD-MBD: A Fresh Look

    Brandi, Lisbet, 2017, In: Journal of Clinical Nephrology and Research. 4, 2, 7 p., 1061.

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: An observational study

    Axelsson Raja, A., Warming, P. E., Nielsen, T. L., Plesner, L. L., Ersbøll, M., Dalsgaard, M., Schou, Morten, Rydahl, C., Brandi, Lisbet & Iversen, Kasper, 2020, In: BMC Nephrology. 21, 1, 413.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 11221128